Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.69 |
| ▸ | KARS1 | Q15046 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.69 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.69 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.69 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.69 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | RXRA | P19793 | 1/20 | 0.67 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.67 |
| ▸ | CDK2 | P24941 | 1/20 | 0.67 |
| ▸ | RXRB | P28702 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6319702 | 1.00 | CYP3A4 (0.69) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL6319708 | 0.87 | CYP3A4 (0.72) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL15899658 | 0.87 | CYP3A4 (0.72) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL6280790 | 0.87 | CYP3A4 (0.72) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL20866406 | 0.85 | CYP3A4 (0.72) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL18019013 | 0.83 | KARS1 (0.79) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL18431215 | 0.82 | CYP3A4 (0.66) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL22476430 | 0.82 | CYP3A4 (0.66) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL9775101 | 0.82 | CYP3A4 (0.66) | CYP3A4KARS1MEN1KMT2ATSHR | |
| SCHEMBL16298228 | 0.82 | CYP3A4 (0.80) | CYP3A4KARS1MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344278-A | Rosin amino acid compound and preparation method and application thereof | 广西中医药大学 | 2024-07-16 | — | — | CN | claimed |
| CN-117551000-A | Dehydroabietyl acid group aggregation-induced red light compound, preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2024-02-13 | — | — | CN | claimed |
| CN-114539159-B | Dehydroabietyl Schiff base multi-ion functional fluorescent probe and preparation method and application thereof | 南京林业大学 | 2023-12-01 | — | — | CN | claimed |
| CN-116217429-A | Dehydroabietyl acid anilide compound acting with DNA as well as preparation method and application thereof | 南京林业大学 | 2023-06-06 | — | — | CN | claimed |
| CN-114349532-B | Liquid preparation for early curing of concrete and early curing method of concrete | 北京易晟元环保工程有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-114349532-A | Liquid preparation for early curing of concrete and early curing method of concrete | 北京易晟元环保工程有限公司 | 2022-04-15 | — | — | CN | claimed |
| US-20210369702-A1 | METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE | FIBROGEN, INC. (US) | 2021-12-02 | — | — | US | claimed |
| US-10927081-B2 | Enhanced erythropoiesis and iron metabolism | FIBROGEN, INC. (US) | 2021-02-23 | — | — | US | claimed |
| US-10894774-B2 | Enhanced erythropoiesis and iron metabolism | FIBROGEN, INC. (US) | 2021-01-19 | — | — | US | claimed |
| US-10882827-B2 | Enhanced erythropoiesis and iron metabolism | FIBROGEN, INC. (US) | 2021-01-05 | — | — | US | claimed |
| US-4948813-A | Benzylketone phospholipase A2 inhibitors | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-08-14 | — | — | US | claimed |
| US-4921571-A | ALKANE SULFONIC ACID, INORGANIC NITRATE, INHIBITOR, PRINTED CIRCUIT BOARDS | MACDERMID, INCORPORATED (US) | 1990-05-01 | — | — | US | claimed |
| US-4707189-A | Biostable compositions and the aqueous solutions thereof as thickeners for aqueous-based systems | HERCULES INCORPORATED (US) | 1987-11-17 | — | — | US | claimed |
| US-4596863-A | Maleic anhydride-alpha, beta unsaturated compound | BAYER AKTIENGESELLSCHAFT (DE) | 1986-06-24 | — | — | US | claimed |
| EP-0104528-B1 | REACTIVE SIZING AGENT FOR PAPER | BAYER AG (DE) | 1985-11-13 | — | — | EP | claimed |
| US-4205995-A | Pigment compositions | CIBA-GEIGY CORPORATION (US) | 1980-06-03 | — | — | US | claimed |
| EP-0010842-A1 | Polyurethane foam and method of preparation thereof | UNIROYAL LTD. (CA) | 1980-05-14 | — | — | EP | claimed |
| US-4171309-A | Process for the preparation of a solvent-stable, red-shade copper phthalocyanine pigment composition | CIBA-GEIGY CORPORATION (US) | 1979-10-16 | — | — | US | claimed |
| US-4135944-A | PIGMENT COMPOSITION | CIBA-GEIGY CORPORATION (US) | 1979-01-23 | — | — | US | claimed |
| US-4110109-A | Oxidation inhibition of steel wool in silver recovery | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-08-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210369702-A1 | METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE | HIF1AN, HIF1A, EGLN2 | CYP3A4 3235/4885KARS1 2365/4885MEN1 3699/4885 |
| US-10894774-B2 | Enhanced erythropoiesis and iron metabolism | EPOR, HAMP, TFRC | CYP3A4 3402/4885KARS1 3327/4885MEN1 3714/4885 |
| US-10927081-B2 | Enhanced erythropoiesis and iron metabolism | EPOR, HAMP, TFRC | CYP3A4 3402/4885KARS1 3327/4885MEN1 3714/4885 |
| US-10882827-B2 | Enhanced erythropoiesis and iron metabolism | EPOR, HAMP, TFRC | CYP3A4 3073/4885KARS1 3829/4885MEN1 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.